Capecitabine - Open Access .click

Results 191 to 200 of about 67,411 (205)

Some of the next articles are maybe not open access.

Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients.

European Journal of Cancer, 2022
BACKGROUND Despite the large number of patients with early breast cancer (EBC) who have been treated with capecitabine in randomised trials, no individual patient data meta-analysis has been conducted.
M. V. van Mackelenbergh +16 more
semanticscholar +1 more source

BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care

Expert Review of Gastroenterology & Hepatology, 2020
Biliary tract cancer (BTC) is a heterogeneous group of aggressive malignancies comprising ampulla of Vater cancer, gallbladder cancer, extrahepatic cholangiocarcinoma, and intrahepatic cholangiocarcinoma; unfortunately, the incidence of distant and ...
A. Rizzo, G. Brandi
semanticscholar +1 more source

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.

The Lancet Oncology, 2019
BACKGROUND Endocrine treatment is recommended by clinical guidelines as the preferred treatment option for premenopausal as well as postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.
Yeon-Hee Park +20 more
semanticscholar +1 more source

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.